Ei 2013.11.018 20ktd 20logo 20white 20on 20gradient 20background 20copy
Gust 20kromosome

KromaTiD Inc.

KromaTiD develops and markets proprietary products and services for studying the root causes of genetic diseases including cancers and developmental disorders.

  • Stage $500K in TTM Revenue
  • Industry Biotechnology
  • Location Fort Collins, CO, USA
  • Currency USD
  • Founded December 2007
  • Employees 5
  • Website kromatid.com

Company Summary

KromaTiD, Inc. is commercializing a breakthrough genomic technology that will advance precision medicine. KromaTiD has moved past proof of concept and is selling proprietary products and services that are being applied to further the understanding of the genetic basis of cancers and developmental disorders.


  • 634fd606 91e2 4deb 9f86 7882dbdbb7de
    Board Chairman

    Former Divisional Vice President at Abbott and currently holds a number of positions. President and CEO, Vidasym, Inc., Founder and CSO, VetDC, Inc., and Vice President, CSU Ventures.

  • 126fd485 fad7 462d 9cee 1dc52f41ca9d
    President & COO

    20 years of pharmaceutical and biotechnology industry experience in the cytogenetic markets. Former COO at Evia Medical and GM of Proligo LLC. Former lead project engineer at NeXstar Pharmaceuticals and Hoffmann-La Roche. Ph.D. in Chemical Engineering from NC State.

  • 20 years hands on experience commercializing technology and building successful ventures in life sciences. Former CEO of Gentel Biosciences and VP of Sales and Marketing PanVera Corporation. Former research scientist at Pfizer and Abbott. Holds MS and BS degrees from UW-Madison.


  • Default avatar
    Rex O’Neal, J.D.– Sage Law
    Corporate Attorney
    Default avatar
    Mellisa Clary, CPA; Kruger & Clary
    Default avatar
    Barry Swanson, J.D. - Swanson & Bratschun
    IP Attorney

Previous Investors

  • Default avatar
    Default avatar
    Non-Dilutive (SBIR and Others)
    Default avatar
  • Default avatar
    CSU Research Foundation